What Is GLP-1? A Complete, Plain-English Guide

What does GLP-1 stand for?

GLP-1 is short for glucagon-like peptide-1. Breaking that down: it's a peptide (a small protein), and its structure resembles another hormone called glucagon — hence "glucagon-like." The "1" distinguishes it from a related hormone, GLP-2, that's produced from the same parent molecule but does a completely different job.

You'll see it written several ways online — GLP-1, GLP1, GLP 1, or simply "GLP." They all refer to the same hormone. It belongs to a family of hormones called incretins: hormones released by the gut in response to food that amplify the body's insulin response. The other major incretin is GIP (glucose-dependent insulinotropic polypeptide), which becomes important when we talk about newer drugs like tirzepatide.

What does GLP-1 do in the body?

GLP-1 is made by specialized cells called L-cells that line your lower small intestine and colon. When food — particularly carbohydrates, fats and protein — reaches the gut, these cells release GLP-1 into the bloodstream within minutes. From there, it has several coordinated effects:

• It triggers insulin — but only when you need it. GLP-1 prompts the pancreas to release insulin in a glucose-dependent way, meaning it works hardest when blood sugar is high and eases off when it's normal. This is why GLP-1 drugs rarely cause dangerous low blood sugar on their own.
• It suppresses glucagon. Glucagon is the hormone that tells your liver to dump sugar into the blood. GLP-1 turns this down after meals, preventing blood sugar spikes.
• It slows gastric emptying. Food stays in your stomach longer, so sugar enters the blood more gradually and you feel full sooner and for longer.
• It acts on the brain. GLP-1 receptors in the hypothalamus and brainstem influence appetite and satiety. Activating them reduces hunger and "food noise" — the constant background pull toward eating.

Here's the catch that makes the whole drug class possible: your own GLP-1 is destroyed almost instantly. An enzyme called DPP-4 chops it up within about one to two minutes of release. That's fine for a natural meal signal, but useless as a medicine. The breakthrough behind modern GLP-1 drugs was redesigning the molecule to resist DPP-4, so a single dose keeps working for days.

What is a GLP-1 receptor agonist?

A receptor agonist is any molecule that binds to a cell receptor and "switches it on," producing the same effect the natural hormone would. So a GLP-1 receptor agonist (often shortened to GLP-1 RA) is a drug that locks onto the GLP-1 receptor and mimics the hormone's actions — but in a body that no longer clears it in seconds.

Scientists achieve this longevity in two main ways: by altering the peptide's structure so DPP-4 can't recognize it, and by attaching a fatty-acid chain that binds to a blood protein called albumin, keeping the drug circulating. The result is a medicine that delivers GLP-1's blood-sugar and appetite effects continuously, which is far more powerful than the brief natural pulses you get from a meal.

The best-known GLP-1 receptor agonists include:

• Semaglutide — sold as Ozempic and Wegovy (weekly injections) and Rybelsus (a daily pill).
• Liraglutide — sold as Victoza (diabetes) and Saxenda (weight), taken as a daily injection.
• Dulaglutide (Trulicity) and exenatide (Byetta, Bydureon) — older weekly or twice-daily options.

Tirzepatide (Mounjaro and Zepbound) is technically a step beyond a pure GLP-1 RA: it activates both the GLP-1 and GIP receptors, which is why it's sometimes called a "twincretin" or dual agonist. We cover the full lineup in our GLP-1 medications guide.

GLP-1 vs. GIP vs. "GLP-3": clearing up the confusion

As these drugs have exploded in popularity, so has confusion about the names. Let's settle the common questions:

• GLP-2 is real, but it's a different hormone made from the same precursor as GLP-1. It promotes growth of the intestinal lining and is the basis of a drug (teduglutide) used for short bowel syndrome — nothing to do with weight or diabetes.
• "GLP-3" does not exist. There is no hormone or drug class by that name. Almost everyone searching for "GLP-3" or "glp 3 peptide" is actually looking for retatrutide, an experimental drug.
• Retatrutide is an investigational triple agonist that hits three receptors at once — GLP-1, GIP and glucagon. In trials it has produced striking weight loss, but as of 2026 it is still in clinical testing and not FDA-approved. So to answer a popular question: yes, retatrutide includes GLP-1 activity, but it is not "a GLP-1" in the narrow sense — it's a triple agonist.

What are GLP-1 drugs used for?

GLP-1 receptor agonists were first developed for type 2 diabetes, where they lower blood sugar (typically reducing A1c by around 1–2 percentage points) without the weight gain or low-sugar risk of some older diabetes drugs. Their powerful appetite effects then led to a second, separate set of approvals for chronic weight management.

Today, depending on the specific drug, GLP-1 medications are FDA-approved to:

• Manage type 2 diabetes (e.g., Ozempic, Mounjaro, Trulicity, Victoza, Rybelsus).
• Treat obesity or overweight with a weight-related condition (e.g., Wegovy, Zepbound, Saxenda).
• Reduce cardiovascular risk — semaglutide is approved to lower the risk of heart attack and stroke in certain adults, based on large outcome trials.
• Protect the kidneys and address related conditions, with indications continuing to expand.

It's worth knowing that the same molecule can have different brand names for different uses. Semaglutide is "Ozempic" for diabetes and "Wegovy" for weight loss; tirzepatide is "Mounjaro" for diabetes and "Zepbound" for weight loss. When a diabetes-branded version is used purely for weight loss, that's an off-label use — legal and common, but it affects insurance coverage. See our cost and insurance guide for why that matters.

How well do GLP-1 drugs work?

The results that drove the headlines are genuinely large by the standards of weight-loss medicine. In major clinical trials:

*Trial averages alongside lifestyle changes; individual results vary widely. See our weight-loss guide for the full breakdown.

Two honest caveats matter here. First, these are averages — some people lose far more, others much less, and a minority don't respond. Second, the effect depends on continuing the medication: studies consistently show that most people regain a large share of lost weight after stopping, because the underlying biology of appetite returns. GLP-1 drugs treat obesity as the chronic condition it is, rather than curing it.

Who can take GLP-1 medications — and who shouldn't?

Eligibility is a medical decision, but in general these drugs are considered for adults with type 2 diabetes, or for weight management in adults with a BMI of 30+ (or 27+ with a weight-related condition such as high blood pressure or sleep apnea). Some are now approved for adolescents as well.

They are not appropriate for everyone. GLP-1 drugs carry a boxed warning and should generally be avoided by people with a personal or family history of medullary thyroid carcinoma or the genetic condition MEN 2, and by anyone who has had pancreatitis or has certain other conditions. They are not used in pregnancy. This is exactly the kind of decision to make with a clinician rather than online.

What are the side effects?

Because GLP-1 slows digestion, the most common side effects are gastrointestinal: nausea, vomiting, diarrhea, constipation and abdominal discomfort. These are usually worst when starting or increasing the dose and tend to ease over time, which is why doctors "titrate" — starting low and stepping up slowly. Rarer but more serious risks include pancreatitis and gallbladder problems. We cover the full picture, including how to reduce nausea, in our dedicated GLP-1 side effects guide.

Can you boost GLP-1 naturally?

Yes — to a degree. Your gut releases more GLP-1 in response to certain foods and habits, which is part of why these support healthy appetite and blood sugar:

• Protein and healthy fats are strong natural triggers for GLP-1 release.
• Soluble and fermentable fiber (oats, legumes, vegetables) feeds gut bacteria that produce short-chain fatty acids, which stimulate L-cells.
• Exercise and a diverse gut microbiome are both associated with healthier incretin responses.

What you should be skeptical of is the booming market in supplements marketed as "natural GLP-1 boosters" or "Ozempic alternatives." Most rely on fiber or appetite-blunting ingredients and produce effects that are real but small compared with prescription drugs — and the marketing claims often outrun the evidence. We dig into what the research actually supports in our natural GLP-1 guide.

The bottom line

GLP-1 is a hormone your body already makes to manage blood sugar and tell you when you've had enough to eat. The drugs everyone's talking about — Ozempic, Wegovy, Mounjaro, Zepbound — are clever, long-lasting copies of that hormone. They're effective tools for type 2 diabetes and obesity, with growing evidence for protecting the heart and kidneys, but they require a prescription, medical supervision, and a realistic understanding that they manage these conditions rather than cure them.

From here, a good next step is understanding how GLP-1 drives weight loss, or comparing the specific medications to see how they differ.

Frequently asked questions